CNSP

CNS Pharmaceuticals, Inc.

Pharmaceutical PreparationsNasdaqNon-accelerated filer<br>Smaller reporting company

Total Trades

Buys

Sells

Largest Trade

$100K–$500K

Insiders

Institutional Funds

Inst. Value

$500K+

Activist Filings

Insider Trades

Insider	Title	Type	Value	Shares	Price	Date
Gumulka Jerzy	Director	BUY	$1K–$15K	33K	$0.30	Feb 6, 2024
Evans Carl Anthony	Director	BUY	$1K–$15K	33K	$0.30	Feb 6, 2024
Downs Christopher	CFO	BUY	$15K–$50K	67K	$0.30	Feb 6, 2024
Climaco John M	CEO	BUY	$15K–$50K	167K	$0.30	Feb 6, 2024
Downs Christopher	CFO	BUY	$15K–$50K	27K	$1.27	Aug 23, 2023
Climaco John M	CEO	BUY	$1K–$15K	3K	$1.80	Aug 16, 2023
Priebe Waldemar	10% Owner	SELL	$100K–$500K	94K	$1.41	Aug 1, 2023
Gumulka Jerzy	Director	BUY	$1K–$15K	3K	$1.70	Apr 21, 2023
Downs Christopher	CFO	BUY	$1K–$15K	3K	$3.20	Apr 18, 2023
Gumulka Jerzy	Director	BUY	$1K–$15K	7K	$0.74	Apr 17, 2023
Climaco John M	CEO	BUY	$1K–$15K	15K	$0.69	Apr 14, 2023

🔓Seeing ranges? Sign in for exact trade values — free forever

13F filings as of Dec 31, 2025 · 8 funds holding

Fund	Shares	Value	Type
Stonepine Capital Management, LLC	49K	$100K–$500K	SH
Ikarian Capital, LLC	46K	$100K–$500K	SH
DRW Securities, LLC	15K	$50K–$100K	SH
UBS Group AG	61	<$1K	SH
Sound Income Strategies, LLC	16	<$1K	SH
BARRETT & COMPANY, INC.	8	<$1K	SH
MAI Capital Management	3	<$1K	SH
DANSKE BANK A/S	1	<$1K	SH